Boehringer Ingelheim Corporation Opens ‘Centre Of Competence’ Opens As Part Of A €100m China Plan
Oustourcing Pharma -- Boehringer Ingelheim has opened its ‘Centre of Competence’ (CoC) in Shanghai to optimise API and chemical intermediates sourcing in China.